共有 50 筆近期內部人交易記錄紀錄，涉及 HCA Healthcare, Inc. (HCA), 包括 13 筆買入 和 29 筆賣出. 內部人買入總額為 $54.59M 內部人賣出總額為 $58.8M.
近期活躍的重要內部人包括 Mcalevey Michael R, Wyatt Christopher F., Berres Jennifer. 內部人交易記錄可以揭示公司管理層對股票估值和未來前景的看法.
內部人交易記錄 — HCA
| 日期 |
姓名 |
職位 |
交易類型 |
股數 |
平均價格 |
總價值 |
持股數量 |
| 2026-02-18 |
Mcalevey Michael R |
EVP & Chief Legal & Admin Off. |
知情賣出 |
1,694 |
$533.38 |
$903.54K |
8,853 |
| 2026-02-13 |
Mcalevey Michael R |
EVP & Chief Legal & Admin Off. |
期權行權（賣出） |
5,000 |
$236.61 |
$1.18M |
8,860 |
| 2026-02-11 |
Wyatt Christopher F. |
SVP & Controller |
知情賣出 |
4,000 |
$505.00 |
$2.02M |
44,379 |
| 2026-02-11 |
Berres Jennifer |
SVP & Chief Human Res. Officer |
知情賣出 |
4,010 |
$526.17 |
$2.11M |
11,993 |
| 2026-02-10 |
Hazen Samuel N |
CEO |
RSU 預扣稅 |
21,323 |
$502.05 |
$10.71M |
64,842 |
| 2026-02-10 |
Foster Jon M |
EVP and COO |
RSU 預扣稅 |
5,888 |
$502.05 |
$2.96M |
23,062 |
| 2026-02-10 |
Cuffe Michael S. |
EVP and Chief Clinical Officer |
RSU 預扣稅 |
3,501 |
$502.05 |
$1.76M |
32,080 |
| 2026-02-10 |
Wyatt Christopher F. |
SVP & Controller |
RSU 預扣稅 |
1,034 |
$502.05 |
$519.12K |
48,379 |
| 2026-02-10 |
Berres Jennifer |
SVP & Chief Human Res. Officer |
RSU 預扣稅 |
2,515 |
$502.05 |
$1.26M |
20,013 |
| 2026-02-10 |
Mcalevey Michael R |
EVP & Chief Legal & Admin Off. |
RSU 預扣稅 |
3,006 |
$502.05 |
$1.51M |
8,853 |
| 2026-02-10 |
Marks Mike A |
EVP and CFO |
RSU 預扣稅 |
1,690 |
$502.05 |
$848.46K |
3,336 |
| 2026-02-10 |
Rossitto Erica |
SVP & Chief Nurse Executive |
RSU 預扣稅 |
418 |
$502.05 |
$209.86K |
10,407 |
| 2026-02-06 |
Frist Thomas F Jr |
10 Percent Owner |
其他（賣出） |
36,629,188 |
$0.01 |
$366.29K |
- |
| 2026-02-06 |
Frist Thomas F Iii |
10 Percent Owner |
其他（賣出） |
36,629,188 |
$0.01 |
$366.29K |
- |
| 2026-02-06 |
Hercules Holding Ii |
10 Percent Owner |
其他（賣出） |
36,629,188 |
- |
- |
32,282,889 |
| 2026-02-06 |
Frisco Holding Ii |
10 Percent Owner |
其他（賣出） |
36,629,188 |
$0.01 |
$366.29K |
- |
| 2026-02-06 |
Elcan Patricia F |
10 Percent Owner |
其他（賣出） |
36,629,188 |
$0.01 |
$366.29K |
- |
| 2026-02-06 |
Frist William R |
10 Percent Owner |
其他（賣出） |
36,629,188 |
$0.01 |
$366.29K |
- |
| 2026-02-05 |
Foster Jon M |
EVP and COO |
期權行權（賣出） |
29,330 |
$139.06 |
$4.08M |
- |
| 2026-02-05 |
Wyatt Christopher F. |
SVP & Controller |
期權行權（賣出） |
10,670 |
$139.06 |
$1.48M |
- |
| 2026-02-04 |
Hazen Samuel N |
CEO |
其他（買入） |
1,045 |
$498.35 |
$520.78K |
16,024 |
| 2026-02-03 |
Hazen Samuel N |
CEO |
知情賣出 |
120 |
$497.18 |
$59.66K |
32,276 |
| 2026-02-03 |
Cuffe Michael S. |
EVP and Chief Clinical Officer |
贈與（送出） |
4,050 |
- |
- |
25,953 |
| 2026-02-01 |
Rossitto Erica |
SVP & Chief Nurse Executive |
未知 |
960 |
$130.56 |
$125.34K |
- |
| 2026-01-30 |
Hazen Samuel N |
CEO |
期權行權（賣出） |
84,360 |
$81.96 |
$6.91M |
- |
| 2026-01-29 |
Hazen Samuel N |
CEO |
限制性股票授予 (RSU) |
55,846 |
$482.53 |
$26.95M |
55,846 |
| 2026-01-29 |
Foster Jon M |
EVP and COO |
限制性股票授予 (RSU) |
11,945 |
$482.53 |
$5.76M |
11,945 |
| 2026-01-29 |
Cuffe Michael S. |
EVP and Chief Clinical Officer |
限制性股票授予 (RSU) |
8,067 |
$482.53 |
$3.89M |
8,067 |
| 2026-01-29 |
Wyatt Christopher F. |
SVP & Controller |
限制性股票授予 (RSU) |
2,560 |
$482.53 |
$1.24M |
2,560 |
| 2026-01-29 |
Berres Jennifer |
SVP & Chief Human Res. Officer |
限制性股票授予 (RSU) |
6,206 |
$482.53 |
$2.99M |
6,206 |
| 2026-01-29 |
Mcalevey Michael R |
EVP & Chief Legal & Admin Off. |
限制性股票授予 (RSU) |
8,067 |
$482.53 |
$3.89M |
8,067 |
| 2026-01-29 |
Marks Mike A |
EVP and CFO |
限制性股票授予 (RSU) |
11,945 |
$482.53 |
$5.76M |
11,945 |
| 2025-11-14 |
Hazen Samuel N |
CEO |
贈與（送出） |
14,830 |
- |
- |
32,276 |
| 2025-11-05 |
Mcalevey Michael R |
EVP & Chief Legal & Admin Off. |
知情賣出 |
3,892 |
$473.79 |
$1.84M |
3,487 |
| 2025-11-05 |
Marks Mike A |
EVP and CFO |
贈與（送出） |
165 |
- |
- |
- |
| 2025-11-03 |
Mcalevey Michael R |
EVP & Chief Legal & Admin Off. |
期權行權（賣出） |
13,170 |
$236.61 |
$3.12M |
- |
| 2025-11-03 |
Marks Mike A |
EVP and CFO |
贈與（收到） |
165 |
- |
- |
165 |
| 2025-10-31 |
Hazen Samuel N |
CEO |
期權行權（賣出） |
58,050 |
$69.58 |
$4.04M |
- |
| 2025-09-08 |
Cuffe Michael S. |
EVP and Chief Clinical Officer |
知情賣出 |
3,836 |
$418.84 |
$1.61M |
31,503 |
| 2025-09-04 |
Cuffe Michael S. |
EVP and Chief Clinical Officer |
期權行權（賣出） |
10,920 |
$173.12 |
$1.89M |
10,000 |
| 2025-07-29 |
Chidsey John |
Director |
限制性股票授予 (RSU) |
496 |
- |
- |
496 |
| 2025-07-15 |
Chidsey John |
Director |
未知 |
- |
- |
- |
3 |
| 2025-05-13 |
Hazen Samuel N |
CEO |
贈與（送出） |
90,076 |
- |
- |
- |
| 2025-05-13 |
Foster Jon M |
EVP and COO |
其他（賣出） |
15,925 |
$367.20 |
$5.85M |
- |
| 2025-05-07 |
Marks Mike A |
EVP and CFO |
其他（賣出） |
285 |
$356.84 |
$101.7K |
- |
| 2025-05-06 |
Marks Mike A |
EVP and CFO |
贈與（送出） |
144 |
- |
- |
144 |
| 2025-04-30 |
Frist William R |
10 Percent Owner |
其他（買入） |
10,505 |
$340.60 |
$3.58M |
1,574,897 |
| 2025-04-29 |
Deparle Nancy Ann |
Director |
限制性股票授予 (RSU) |
645 |
- |
- |
21,401 |
| 2025-04-29 |
Michelson Michael W |
Director |
限制性股票授予 (RSU) |
1,173 |
- |
- |
11,651 |
| 2025-04-29 |
Frist Thomas F Iii |
10 Percent Owner |
限制性股票授予 (RSU) |
1,320 |
- |
- |
14,817 |
■ 知情交易 — 公開市場買賣（最具參考價值）
■ 非知情買入 — 獎勵、期權行權、轉換
■ 非知情賣出 — 稅務代扣、歸屬出售
■ 中性 — 禮贈、信託、到期
